These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25059388)

  • 21. Pediatric ependymoma: biological perspectives.
    Kilday JP; Rahman R; Dyer S; Ridley L; Lowe J; Coyle B; Grundy R
    Mol Cancer Res; 2009 Jun; 7(6):765-86. PubMed ID: 19531565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pediatric neuro-oncology].
    Navajas-Gutiérrez A
    Rev Neurol; 2006 Jul 16-31; 43(2):88-94. PubMed ID: 16838256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
    Wang K; Huang C; Nice EC
    Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma proteomics: status and perspectives.
    Niclou SP; Fack F; Rajcevic U
    J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the treatment of pediatric brain tumors.
    Rutka JT; Kuo JS; Carter M; Ray A; Ueda S; Mainprize TG
    Expert Rev Neurother; 2004 Sep; 4(5):879-93. PubMed ID: 15853514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State of the art chemotherapeutic management of pediatric brain tumors.
    Siegel MJ; Finlay JL; Zacharoulis S
    Expert Rev Neurother; 2006 May; 6(5):765-79. PubMed ID: 16734524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OMICS and brain tumour biomarkers.
    Petrik V; Loosemore A; Howe FA; Bell BA; Papadopoulos MC
    Br J Neurosurg; 2006 Oct; 20(5):275-80. PubMed ID: 17129872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular insights into pediatric brain tumors have the potential to transform therapy.
    Gajjar A; Pfister SM; Taylor MD; Gilbertson RJ
    Clin Cancer Res; 2014 Nov; 20(22):5630-40. PubMed ID: 25398846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical cancer proteomics: promises and pitfalls.
    Alaiya A; Al-Mohanna M; Linder S
    J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic studies of pediatric medulloblastoma tumors with 17p deletion.
    Anagnostopoulos AK; Papathanassiou C; Karamolegou K; Anastasiadou E; Dimas KS; Kontos H; Koutsopoulos A; Prodromou N; Tzortzatou-Stathopoulou F; Tsangaris GT
    J Proteome Res; 2015 Feb; 14(2):1076-88. PubMed ID: 25543836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of pediatric brain neoplasms using Raman spectroscopy.
    Leslie DG; Kast RE; Poulik JM; Rabah R; Sood S; Auner GW; Klein MD
    Pediatr Neurosurg; 2012; 48(2):109-17. PubMed ID: 23154646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy.
    Pai MGJ; Biswas D; Verma A; Srivastava S
    Expert Rev Proteomics; 2023; 20(12):381-395. PubMed ID: 37970632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain tumors in children: a review.
    Lacayo A; Farmer PM
    Ann Clin Lab Sci; 1991; 21(1):26-35. PubMed ID: 2012378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain tumors.
    Chintagumpala M; Gajjar A
    Pediatr Clin North Am; 2015 Feb; 62(1):167-78. PubMed ID: 25435118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Towards a better knowledge of breast cancer physiopathology: the proteomics approach].
    Hamrita B; Ben Nasr H; Hammann P; Kuhn L; Ben Anes A; Dimassi S; Chaieb A; Khairi H; Chahed K
    Ann Biol Clin (Paris); 2012 Oct; 70(5):553-65. PubMed ID: 23047902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iTRAQ-labeling for biomarker discovery.
    Desouza LV; Voisin SN; Siu KW
    Methods Mol Biol; 2013; 1002():105-14. PubMed ID: 23625398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery.
    Lin F; Tan HJ; Guan JS; Lim YP
    Expert Rev Proteomics; 2014 Aug; 11(4):515-30. PubMed ID: 24684179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].
    Gilabert M; Audebert S; Viens P; Borg JP; Bertucci F; Gonçalves A
    Bull Cancer; 2010 Mar; 97(3):321-39. PubMed ID: 20202919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.